Michael Emerson
Overview
Explore the profile of Michael Emerson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
11182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, et al.
PLoS Biol
. 2020 Jul;
18(7):e3000410.
PMID: 32663219
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of...
12.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, et al.
J Cereb Blood Flow Metab
. 2020 Jul;
40(9):1769-1777.
PMID: 32663096
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of...
13.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, et al.
Br J Pharmacol
. 2020 Jul;
177(16):3617-3624.
PMID: 32662519
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of...
14.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, et al.
BMC Vet Res
. 2020 Jul;
16(1):242.
PMID: 32660541
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of...
15.
Taylor K, Smyth E, Rauzi F, Cerrone M, Khawaja A, Gazzard B, et al.
Br J Pharmacol
. 2019 Jan;
176(7):879-889.
PMID: 30681136
Background And Purpose: Some clinical studies have reported increased myocardial infarction in people living with human immunodeficiency virus (HIV) taking the antiretroviral abacavir sulphate (ABC). Given that clinical studies contain...
16.
Taylor K, Emerson M
F1000Res
. 2018 Jun;
7:593.
PMID: 29904600
European and UK legislation requires all animal procedures to be conducted with consideration to reduction, refinement and replacement. In this review, 3Rs developments are discussed in the field of platelet...
17.
Gillespie S, Holloway P, Becker F, Rauzi F, Vital S, Taylor K, et al.
Br J Pharmacol
. 2018 May;
175(16):3333-3346.
PMID: 29797311
Background And Purpose: Platelet activation provides a critical link between inflammation and thrombosis. Sulforaphane (SFN), a naturally occurring isothiocyanate, has been shown to display both anti-inflammatory and anti-thrombotic actions in...
18.
Rauzi F, Smyth E, Emerson M
Thromb Haemost
. 2017 Dec;
117(12):2283-2290.
PMID: 29212116
Mouse models of thromboembolism are frequently used to investigate platelet function in vivo and, according to European Union (EU) legislation, must be conducted in the context of replacement, refinement and...
19.
Smyth E, Solomon A, Birrell M, Smallwood M, Winyard P, Tetley T, et al.
Br J Pharmacol
. 2017 Oct;
174(22):4200.
PMID: 28994116
No abstract available.
20.
Emerson M
Handb Exp Pharmacol
. 2015 Jul;
230:153-62.
PMID: 26162833
Platelets are circulating blood elements with key roles in haemostasis and thrombosis. Platelets are activated by a range of stimuli including exposed subendothelial components. Haemostasis also depends upon the effects...